RTSL (Rapid Therapeutic Science Laboratories) Net Margin %: 0.00% (As of Jun. 2023)


What is Rapid Therapeutic Science Laboratories Net Margin %?

Rapid Therapeutic Science Laboratories RTSL Net Margin % is 0.00% as of Jun. 2023.

Net margin is calculated as Net Income divided by its Revenue. Rapid Therapeutic Science Laboratories's Net Income for the three months ended in Jun. 2023 was $0.05 Mil. Rapid Therapeutic Science Laboratories's Revenue for the three months ended in Jun. 2023 was $0.00 Mil. Therefore, Rapid Therapeutic Science Laboratories's net margin for the quarter that ended in Jun. 2023 was 0.00%.

The historical rank and industry rank for Rapid Therapeutic Science Laboratories's Net Margin % or its related term are showing as below:


RTSL's Net Margin % is not ranked *
in the Diversified Financial Services industry.
Industry Median: 8.24
* Ranked among companies with meaningful Net Margin % only.

Rapid Therapeutic Science Laboratories  (OTCPK:RTSL) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Rapid Therapeutic Science Laboratories Net Margin % Related Terms

Rapid Therapeutic Science Laboratories Net Margin % Historical Data

* Premium members only.

The historical data trend for Rapid Therapeutic Science Laboratories's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapid Therapeutic Science Laboratories Net Margin % Chart

Rapid Therapeutic Science Laboratories Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Dec21 Dec22
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -6,944.44 -286,800.00 0.00

Rapid Therapeutic Science Laboratories Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

RTSL vs VRAYQ, NNMX, ABT: Net Margin % Comparison

For the Shell Companies subindustry, Rapid Therapeutic Science Laboratories's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rapid Therapeutic Science Laboratories Net Margin % vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Rapid Therapeutic Science Laboratories's Net Margin % distribution charts can be found below:

* The bar in red indicates where Rapid Therapeutic Science Laboratories's Net Margin % falls into.


Rapid Therapeutic Science Laboratories Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Rapid Therapeutic Science Laboratories's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-1.795/0
= %

Rapid Therapeutic Science Laboratories's Net Margin for the quarter that ended in Jun. 2023 is calculated as

Net Margin=Net Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=0.046/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Rapid Therapeutic Science Laboratories (RTSL) has a Net Margin % of 0.00% as of Jun. 2023. Net margin is the ratio of total net income to net sales. View historical data on Rapid Therapeutic Science Laboratories and its competitors.
Is Rapid Therapeutic Science Laboratories' Net Margin % too high?
Rapid Therapeutic Science Laboratories' current Net Margin % is 0.00%.
How does Rapid Therapeutic Science Laboratories' Net Margin % compare to VRAYQ and NNMX?
Rapid Therapeutic Science Laboratories' Net Margin % of 0.00% can be compared against companies in the Diversified Financial Services industry. The industry median Net Margin % is 8.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Diversified Financial Services company?
The median Net Margin % among Diversified Financial Services companies is 8.24, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Rapid Therapeutic Science Laboratories and its competitors. For the Diversified Financial Services industry, the median Net Margin % is 8.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rapid Therapeutic Science Laboratories's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rapid Therapeutic Science Laboratories stock overvalued right now?
Rapid Therapeutic Science Laboratories (RTSL) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Rapid Therapeutic Science Laboratories (RTSL), the current Net Margin % is 0.00% as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rapid Therapeutic Science Laboratories Business Description

Address 558 County Road 472, De Leon, TX, USA, 76444
Rapid Therapeutic Science Laboratories Inc currently has no operations and operates as a blank check company.